Septilin
$ 63,00 – $ 83,00Price range: $ 63,00 through $ 83,00
Serophene
$ 40,00 – $ 537,00Price range: $ 40,00 through $ 537,00
Seroflo
$ 110,00 – $ 659,00Price range: $ 110,00 through $ 659,00
Seroflo is an effective inhaler medication designed to manage chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It combines salmeterol, a long-acting bronchodilator that helps keep the airways open, with fluticasone, a potent corticosteroid that reduces lung inflammation. The dual-action formula works to prevent common symptoms like wheezing, shortness of breath, and chest tightness over time. Regular daily use helps stabilize breathing and significantly lowers the risk of sudden flare-ups or worsening of respiratory symptoms. This reliable medication supports better overall lung function, allowing individuals to breathe more comfortably throughout the day and night.
Active substance: fluticasone, Salmeterol
SKU:
Seroflo
Categories: AntiAllergics, Asthma
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Seroflo belongs to a combination class of respiratory medications containing a long-acting beta2-adrenergic agonist (LABA) and an inhaled corticosteroid (ICS). In the United States, inhaled combination therapies containing fluticasone propionate and salmeterol are classified as prescription (Rx) medications dispensed under federal regulations. This drug combination is indicated for long-term controller therapy rather than immediate relief of sudden breathing distress.
Proper administration of maintenance inhalers requires strict adherence to prescribed schedules and administration techniques. Understanding how each active component acts within the pulmonary system ensures optimal therapeutic outcomes while minimizing potential systemic and localized adverse events.
| Parameter | Specification |
|---|---|
| Drug Name | Seroflo (Fluticasone propionate / Salmeterol) |
| Active Ingredients | Fluticasone propionate, Salmeterol xinafoate |
| Therapeutic Class | Inhaled corticosteroid and long-acting beta2-adrenergic agonist combination |
| Route of Administration | Oral inhalation |
| Primary Purpose | Long-term controller therapy for chronic asthma and COPD maintenance |
| Prescription Status | Prescription only (Rx) |
How the Drug Works
Fluticasone propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity within the respiratory tract. It acts by binding to glucocorticoid receptors, inhibiting multiple cell types (such as mast cells, eosinophils, neutrophils, and lymphocytes) and reducing the release of inflammatory mediators including histamine, eicosanoids, leukotrienes, and cytokines. Salmeterol is a selective long-acting beta2-adrenergic agonist (LABA). It acts locally in the lung by binding to beta2-receptors in pulmonary smooth muscle, stimulating intracellular adenyl cyclase, which increases cyclic-3′,5′-adenosine monophosphate (cAMP) levels. Elevated cAMP leads to relaxation of bronchial smooth muscle and inhibition of immediate hypersensitivity mediator release from mast cells. Together, these complementary mechanisms address both persistent mucosal inflammation and airway hyperresponsiveness.
What It’s Used For
This combination inhalation therapy is indicated for the maintenance treatment of asthma in patients requiring regular controller therapy with both an inhaled corticosteroid and a long-acting bronchodilator. It is also indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is important to emphasize that this product is not indicated for the relief of acute bronchospasm. Patients must be equipped with a short-acting beta2-agonist (such as albuterol) for immediate management of acute asthmatic fits or rescue relief during sudden respiratory exacerbations. Any off-label use for non-approved pulmonary indications must be individually evaluated by a licensed prescriber.
Dosing Schedule
Dosing regimens are strictly individualized based on disease severity, patient age, and previous clinical response to respiratory therapies. The medication is administered via oral inhalation, typically prescribed as two inhalations per day spaced approximately 12 hours apart (morning and evening). Patients should rinse their mouth thoroughly with water without swallowing after each inhalation session to reduce the risk of localized fungal infections, such as oropharyngeal candidiasis, and hoarseness. Consistent daily administration at evenly spaced intervals is required to maintain effective therapeutic mucosal levels, even when clinical symptoms are absent. Dose adjustments should only occur under direct clinical supervision by a healthcare professional.
What Happens in the Body
Following oral inhalation, fluticasone propionate acts locally within the lung tissue, with systemic absorption occurring primarily via mucosal transport within the lower respiratory tract. The systemic bioavailability of inhaled fluticasone is relatively low due to extensive first-pass hepatic metabolism via the cytochrome P450 3A4 (CYP3A4) enzyme system. Salmeterol acts locally in the airway smooth muscle, with plasma concentrations generally remaining minimal at standard therapeutic doses. Both active compounds demonstrate high plasma protein binding. Fluticasone propionate metabolites are excreted predominantly in the feces, while salmeterol undergoes extensive hepatic metabolism primarily via hydroxylation before excretion in feces and urine. Pharmacokinetic profile variations may occur in individuals with moderate to severe hepatic impairment.
Compatibility with Other Medicines
Concurrent administration with strong cytochrome P450 3A4 (CYP3A4) inhibitors–such as ketoconazole, itraconazole, clarithromycin, or ritonavir–can lead to increased systemic exposure of both fluticasone propionate and salmeterol. Increased systemic corticosteroid levels may elevate the risk of systemic glucocorticoid effects, including adrenal suppression. Co-administration with non-selective beta-adrenergic blockers (e.g., propranolol) is generally not recommended, as beta-blockers may antagonize the bronchodilating effect of salmeterol and potentially induce severe bronchospasm in susceptible patients. Care must also be taken when combining this medication with potassium-wasting diuretics, monoamine oxidase inhibitors (MAOIs), or tricyclic antidepressants due to potential cardiovascular effects and electrolyte imbalances.
Adverse Reactions
Common adverse effects associated with this combination inhalation therapy include upper respiratory tract infections, nasopharyngitis, headache, pharyngeal irritation, and voice alterations (dysphonia). Oropharyngeal candidiasis (thrush) may develop in the oral cavity and throat; rinsing the mouth with water after administration substantially decreases this risk. Less common systemic effects include tremors, palpitations, anxiety, nervousness, hypokalemia, or hyperglycemia. Prolonged use of high doses of inhaled corticosteroids may be associated with decreased bone mineral density, ocular changes (such as cataracts or glaucoma), and rare instances of adrenal insufficiency. Paradoxical bronchospasm can occur immediately after dosing; if this happens, administration must cease immediately and an alternative fast-acting bronchodilator utilized.
Important Precautions
LABA monotherapy increases the risk of asthma-related death; however, when used in fixed-dose combination with an inhaled corticosteroid, this risk is mitigated. Treatment should not be initiated in patients during rapidly deteriorating or potentially life-threatening episodes of asthma or COPD. Caution is advised in patients with underlying cardiovascular disorders, coronary insufficiency, cardiac arrhythmias, hypertension, diabetes mellitus, thyrotoxicosis, or seizure disorders. Pediatric populations receiving chronic corticosteroid therapy should be monitored for growth velocity. Use during pregnancy or breastfeeding requires careful assessment of maternal benefit versus potential fetal risk by a healthcare professional. Elderly patients generally tolerate standard recommended dosages but require monitoring for co-existing cardiovascular or metabolic conditions.
If You Skip a Dose
If a regularly scheduled dose is missed, the patient should skip the missed dose and resume treatment at the next regularly scheduled time slot. Double dosing or taking extra inhalations to compensate for a missed dose is not recommended, as this increases the likelihood of experiencing beta-agonist side effects such as tachycardia or tremors. Maintaining a consistent daily routine helps ensure stable airway stabilization.
What to Avoid While Taking It
There are no specific direct food restrictions required during therapy with fluticasone propionate and salmeterol inhalation. However, consumption of grapefruit or grapefruit juice should be monitored or avoided, as grapefruit compounds can inhibit CYP3A4 enzymes and potentially increase systemic absorption of the active components. While alcohol does not directly interact with the mechanism of action of salmeterol or fluticasone, excessive alcohol intake can irritate systemic pathways or interfere with overall respiratory health maintenance.
Storage and Expiration
The inhalation device should be stored at controlled room temperature, typically between 68°F and 77°F (20°C to 25°C), away from excessive heat, direct sunlight, and high humidity environments (such as a bathroom cabinet). Keep the device inside its moisture-protective foil pouch until ready for initial use. Containers should be safely stored out of reach of children and pets. Discard the device after the expiration date printed on the packaging or within the specified disposal timeline following removal from the protective foil wrap, whichever comes first.
Red Flags
Certain severe adverse reactions require urgent medical evaluation. Patients and caregivers should recognize key warning signals that necessitate immediate emergency assistance:
- Sudden, severe worsening of breathing distress or severe wheezing immediately after inhalation (paradoxical bronchospasm).
- Signs of an acute allergic reaction, including swelling of the face, lips, tongue, or throat, or severe rash and hives.
- Chest pain, rapid or irregular heartbeat (tachycardia, palpitations), or feeling faint.
- Signs of severe systemic infection or unexplained high fever.
- Symptoms of acute adrenal crisis, such as severe fatigue, muscle weakness, severe nausea, vomiting, or dizziness upon standing.
Common Questions
Is Seroflo intended to stop an acute asthma attack?
No, this combination drug is designed exclusively for daily maintenance control of chronic airway inflammation and constriction. It does not possess a rapid onset of action sufficient to relieve acute bronchospasm or sudden respiratory distress. Patients must always carry a short-acting rescue inhaler, such as albuterol, for emergency relief during sudden breathing episodes.
Why is rinsing the mouth after each dose necessary?
Rinsing the mouth with water and spitting it out after every inhalation removes residual steroid particles from the oral mucosa and pharynx. This practical measure significantly reduces the risk of developing oral candidiasis (a fungal infection commonly known as thrush) and minimizes localized voice hoarseness (dysphonia).
Can this medication be discontinued once symptoms improve?
Discontinuing controller therapy abruptly can cause a return or worsening of chronic underlying inflammation and bronchoconstriction. Maintenance inhalation therapies should only be adjusted or tapered under direct medical guidance from a prescribing provider, even if the patient feels completely symptom-free.
How does hepatic impairment affect the handling of this drug?
Both fluticasone propionate and salmeterol undergo metabolic clearance primarily through hepatic pathways involving CYP3A4 enzymes. Patients with compromised liver function may experience decreased clearance, potentially resulting in elevated systemic drug concentrations and an increased risk of corticosteroid- and beta-agonist-related side effects.
Is it safe to drive or operate machinery after using this inhaler?
This medication generally does not affect the central nervous system or reaction times necessary for operating motor vehicles or machinery. However, if a patient experiences unusual side effects such as tremors, dizziness, or cardiovascular palpitations, they should refrain from driving until these symptoms fully resolve.
This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.
Additional information
| Dosage |
25mcg+250mcg |
|---|---|
| Package |
1 inhaler ,2 inhaler ,3 inhaler ,4 inhaler ,5 inhaler ,6 inhaler ,7 inhaler ,8 inhaler |
| Ενεργός Ουσία | , |
Related products
Alavert
$ 47,00 – $ 118,00Price range: $ 47,00 through $ 118,00
Active substance: Loratadine
More Details
This product has multiple variants. The options may be chosen on the product page
Astelin
$ 46,00 – $ 193,00Price range: $ 46,00 through $ 193,00
Active substance: Azelastine
More Details
This product has multiple variants. The options may be chosen on the product page
Atarax
$ 42,00 – $ 150,00Price range: $ 42,00 through $ 150,00
Active substance: Hydroxyzine
More Details
This product has multiple variants. The options may be chosen on the product page
Claritin
$ 43,00 – $ 143,00Price range: $ 43,00 through $ 143,00
Active substance: Loratadine
More Details
This product has multiple variants. The options may be chosen on the product page
Flixotide Nasal Spray 100 doses
$ 54,00 – $ 220,00Price range: $ 54,00 through $ 220,00
Active substance: fluticasone
More Details
This product has multiple variants. The options may be chosen on the product page
Haridra
$ 48,00
Active substance: Haridra
More Details
This product has multiple variants. The options may be chosen on the product page
Montair
$ 19,00 – $ 45,00Price range: $ 19,00 through $ 45,00
Active substance: Montelukast
More Details
This product has multiple variants. The options may be chosen on the product page
Prednisolone
$ 40,00 – $ 210,00Price range: $ 40,00 through $ 210,00
Active substance: prednisolone
More Details
This product has multiple variants. The options may be chosen on the product page
